IL-6 as a keystone cytokine in health and disease CA Hunter, SA Jones Nature immunology 16 (5), 448-457, 2015 | 2719 | 2015 |
Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1894 | 2019 |
Control of effector CD8+ T cell function by the transcription factor Eomesodermin EL Pearce, AC Mullen, GA Martins, CM Krawczyk, AS Hutchins, ... Science 302 (5647), 1041-1043, 2003 | 1264 | 2003 |
Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system JS Stumhofer, A Laurence, EH Wilson, E Huang, CM Tato, LM Johnson, ... Nature immunology 7 (9), 937-945, 2006 | 1196 | 2006 |
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions CA Hunter Nature Reviews Immunology 5 (7), 521-531, 2005 | 1118 | 2005 |
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 JS Stumhofer, JS Silver, A Laurence, PM Porrett, TH Harris, LA Turka, ... Nature immunology 8 (12), 1363-1371, 2007 | 999 | 2007 |
Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation RA Kastelein, CA Hunter, DJ Cua Annu. Rev. Immunol. 25 (1), 221-242, 2007 | 962 | 2007 |
Anti–IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis Y Chen, CL Langrish, B Mckenzie, B Joyce-Shaikh, JS Stumhofer, ... The Journal of clinical investigation 116 (5), 1317-1326, 2006 | 783 | 2006 |
NF-κB family of transcription factors: central regulators of innate and adaptive immune functions J Caamano, CA Hunter Clinical microbiology reviews 15 (3), 414-429, 2002 | 775 | 2002 |
Cytokine storms: understanding COVID-19 N Mangalmurti, CA Hunter Immunity 53 (1), 19-25, 2020 | 749 | 2020 |
Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection G Oldenhove, N Bouladoux, EA Wohlfert, JA Hall, D Chou, S O'Brien, ... Immunity 31 (5), 772-786, 2009 | 669 | 2009 |
Modulation of innate immunity by Toxoplasma gondii virulence effectors CA Hunter, LD Sibley Nature Reviews Microbiology 10 (11), 766-778, 2012 | 659 | 2012 |
The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection A Villarino, L Hibbert, L Lieberman, E Wilson, T Mak, H Yoshida, ... Immunity 19 (5), 645-655, 2003 | 615 | 2003 |
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies M Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ... The Journal of clinical investigation 126 (10), 3814-3826, 2016 | 614 | 2016 |
Trafficking of immune cells in the central nervous system EH Wilson, W Weninger, CA Hunter The Journal of clinical investigation 120 (5), 1368-1379, 2010 | 603 | 2010 |
Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling JM Brewer, M Conacher, CA Hunter, M Mohrs, F Brombacher, ... The Journal of Immunology 163 (12), 6448-6454, 1999 | 571 | 1999 |
Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells TH Harris, EJ Banigan, DA Christian, C Konradt, ED Tait Wojno, K Norose, ... Nature 486 (7404), 545-548, 2012 | 562 | 2012 |
The composition and signaling of the IL-35 receptor are unconventional LW Collison, GM Delgoffe, CS Guy, KM Vignali, V Chaturvedi, ... Nature immunology 13 (3), 290-299, 2012 | 539 | 2012 |
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. CM Coughlin, KE Salhany, M Wysocka, E Aruga, H Kurzawa, AE Chang, ... The Journal of clinical investigation 101 (6), 1441-1452, 1998 | 526 | 1998 |
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin AM Intlekofer, A Banerjee, N Takemoto, SM Gordon, CS DeJong, H Shin, ... Science 321 (5887), 408-411, 2008 | 500 | 2008 |